The global market for hepatitis diagnostics is the focus of analysis of a recent market intelligence report by Transparency Market Research. The report presents a detailed overview of the present state of the market and gives a comprehensive forward-looking overview of the market from 2012 through 2018. The report is titled “Hepatitis Diagnostic Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 – 2018.”
Download Exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1281
Diagnostic tests for hepatitis are among the most common infectious disease tests undertaken at clinics and medical labs across the globe. Hepatitis is a disease characterized by the inflammation of liver, often leading to other complications such as liver failure, anorexia, jaundice, and cirrhosis. When left untreated, hepatitis can lead to severe health issues that can crop up even after years or decades of inactivity. Hepatitis is generally of two varieties: Acute, which lasts for a period less than six months, and chronic hepatitis, which lasts for longer periods.
Hepatitis is caused due to a group of viruses called the hepatitis viruses, including the varieties A, B, C, D, and E. Of these, the most observed varieties of hepatitis infections are caused by hepatitis A (HPA), hepatitis B (HPB), and Hepatitis C (HPC). According to the World Health Organization, at least 500,000 people die every year out of nearly 350 mn infections caused due to any one form of the hepatitis virus.
The global hepatitis diagnostics market has gained significant traction over the past few years owing to the rising focus of government bodies on developing healthcare infrastructures and on raising awareness regarding the early diagnosis of hepatitis infections. The implementation of nation-wide awareness and treatment programs such as the national HBV elimination strategy in the U.S. in 1991, the rate of prevalence of new HBV cases has declined by more than 80%. However the prevalence of HBV continues to rise across other parts of the globe, and HCV, sans a proper cure or vaccine, still remains a major threat for the entire world.
It is thus the rising prevalence of HBV and HCV that is driving the global hepatitis diagnostics market. Prevention and control efforts throughout the globe are also the major drivers of the global hepatitis diagnostics market on a global front.
The hepatitis diagnostics market comprises an array of tests meant for diagnosing various stages of infections and treatment. The most common hepatitis infection tests undertaken across the globe include reflex and confirmatory tests, tests that evaluate the stage of infection, tests for confirming chronic and acute infections, and tests that monitor the patient during therapy.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453